Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Neurodegeneration & Neural Signaling

Fueling Discovery in the Etiology, Pathology, and Treatment of Neurodegenerative Disease

It is estimated the aging worldwide population will result in over 100 million sufferers of dementia by the year 2050, a postulate that continues to drive major research efforts in neurodegenerative diseases and the associated loss of cognitive function. Diseases such as Alzheimer’s (AD), Parkinson’s (PD), Huntington’s (HD), and Amyotrophic Lateral Sclerosis (ALS) are considered diseases of protein homeostasis (proteostasis), characterized by loss of specific neuronal populations, and the presence of inclusion bodies consisting of insoluble, unfolded proteins. Drug development programs for treatment of these diseases include modulators of key proteins and enzymes that regulate proper protein folding, modification, and clearance, seeking to reverse or prevent the accumulation of protein aggregates and toxic intermediates.


Phopho-Tau antibodies available through Axxora platform

Early phosphorylation markers

Tau (phospho Thr231)
Tau (phospho Ser262)


Biomarkers of Synaptic and Neuronal Loss

Neurofilament Light Chain (NfL)
Neurogranin (Ng)


Other neuro biomarkers available through Axxora platform

Synuclein (phospho Ser129), GFAP, sTREM

Protein Aggregation, Autophagy, and Cytotoxicity

Although the mechanism may vary from one class of neurodegenerative disease to another, the principle pathology of AD, PD, HD, and ALS are similar: the cell’s defense mechanisms against protein aggregation (i.e., molecular chaperones, protein degradation & recycling pathways) become overwhelmed, leading to structural defects, apoptosis, and ensuing cognitive defects associated with loss or impairment of neural cell function.


Protein Folding & Aggregation

PROTEOSTAT® Aggresome Detection Kit
Heat Shock Proteins & Oxidative Stress

Aggregate Clearance & Survival

CYTO-ID® Autophagy Detection Kit
p62 & NBR1 ELISA Kits
Autophagy Compound Library
LYSO-ID® Red & Green Detection Kits
Ubiquitin & Proteasome


MITO-ID Membrane Potential
Apoptosis/Necrosis Detection Kit
Apoptosis ELISA Kits


Neuroactive Peptide & Second Messenger Detection

As our understanding of neurodegenerative disease origins increases, so does the need for innovative, high quality research tools for developing potential therapeutics. The breadth of Enzo’s expertise across research disciplines from proteostasis and cell analysis, to small molecule chemistry and assay development provides a unique collection of innovative reagents and assays to assess the impact of neurodegeneration on critical neural signaling networks.


Neuroactive Peptide & Stress Hormone ELISAs

Put our expertise in building ultrasensitive, high-specificity ELISAs for small molecule detection to work for you!

Cyclic Nucleotide ELISA Kits

The most sensitive colorimetric ELISA kits for detection of cAMP and cGMP, key second messenger signaling molecules

FLUOFORTE® Calcium Assay Kits

Brighter, More Robust Fluorescent Calcium Mobilization Assays


Neuromodulating Compounds

Focused Compound Libraries for Neuromodulator Screening

Tired of procuring small molecules from multiple sources? Enzo has a long and successful history of identifying, synthesizing, and commercializing known bioactives for use as research tool compounds and assembling focused sets of compounds for chemical genomics, receptor de-orphaning, drug repurposing, pathway analysis, and more.


Worry-free Neuroscience Antibodies

Enzo offers over 3000 widely cited and thoroughly validated antibodies, including nearly 500 for key markers of neurodegenerative disease, GPCRs, nerve cell structure proteins, and neural signal transduction. Each of our antibodies is backed by our Worry-free Antibody Trial Program.

  • Neurotransmitters
  • Neurotransmitter Biosynthesis
  • Neurotransmitter Receptors
  • Neurodegenerative Markers
  • Synaptic Vessicle Markers
  • Ion Channel Antibodies


Neuronal Cell Transfection Reagent

NUPHERIN™ is a biochemical transfection reagent consisting of a cationic peptide fused to a non-classical nuclear localization sequence. The cationic peptide facilitates electrostatic interactions between the DNA and the peptide, and the nuclear localization sequence utilizes the endogenous nuclear transport machinery to deliver the DNA to the nucleus. The end result is high efficiency transfection in non-dividing cells.

NUPHERIN™ Transfection Reagent

A peptide based reagent combines a non-classical nuclear localization sequence (M9) with a nucleotide binding domain, to help transport DNA into the transfected cell's nucleus.

  • Ultra high-efficiency lipofection of neuronal, ganglion and other difficult to transfect cells
  • Fast, simple and reliable protocol. Ready to transfect in 15 minutes.
  • Compatible with your current transfection protocol
  • Requires no special equipment


Related Information and Documents

Latest Literature

Essential Research Tools for Neurodegeneration & Neural Signaling
Neuroscience Antibodies for IHC

Recommend this page